FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

73579000: Carbidopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
122178011 Carbidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
122179015 MK-486 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3736797013 Alpha-methyldopa hydrazine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
462701000241110 carbidopa (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
797681000172110 carbidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa est un(e) (attribut) Antiparkinsonian agent (substance) false Inferred relationship Some
Carbidopa est un(e) (attribut) Co-careldopa (substance) false Inferred relationship Some
Carbidopa est un(e) (attribut) Co-careldopa (product) false Inferred relationship Some
Carbidopa est un(e) (attribut) Dihydroxyphenylalanine true Inferred relationship Some
Carbidopa est un(e) (attribut) inhibiteur de la dopa-décarboxylase true Inferred relationship Some
Carbidopa Has disposition (attribute) Dopamine receptor agonist (disposition) true Inferred relationship Some
Carbidopa Has disposition (attribute) Dihydroxyphenylalanine decarboxylase inhibitor (disposition) true Inferred relationship Some
Carbidopa est un(e) (attribut) produit chimique catégorisé selon sa fonction false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only carbidopa (medicinal product) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 1
Product containing only carbidopa and entacapone and levodopa (medicinal product) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 3
Product containing only carbidopa and levodopa (medicinal product) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Product containing only carbidopa and levodopa in oral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 3
Carbidopa and levodopa only product in enteral dose form a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Carbidopa only product in oral dose form a pour principe actif (attribut) True Carbidopa Inferred relationship Some 1
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 250 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa anhydrous Is modification of (attribute) True Carbidopa Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has precise active ingredient True Carbidopa Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 3
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa- and levodopa-containing product in oromucosal dose form a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Some 3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 3
Carbidopa measurement élément (attribut) True Carbidopa Inferred relationship Some 1
Levodopa with carbidopa (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa 10mg/100mg tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa 25mg/100mg tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa 25mg/250mg tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa 50mg/200mg m/r tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa 25mg/100mg m/r tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 25 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa + levodopa 50mg/200mg m/r tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 10 mg and levodopa 100 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 25 mg and levodopa 100 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 25 mg and levodopa 250 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa + levodopa 25mg/100mg m/r tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Product containing carbidopa (medicinal product) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 1
Product containing carbidopa and levodopa (medicinal product) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
médicament contenant lévodopa et carbidopa et entacapone a pour principe actif (attribut) True Carbidopa Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Co-careldopa (substance) est un(e) (attribut) False Carbidopa Inferred relationship Some
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet (product) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa + levodopa adverse reaction Causative agent False Carbidopa Inferred relationship Some 2
Allergy to carbidopa and levodopa Causative agent False Carbidopa Inferred relationship Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some
Product containing carbidopa and levodopa in oral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Carbidopa measurement Has measured component False Carbidopa Inferred relationship Some
Carbidopa monohydrate (substance) est un(e) (attribut) False Carbidopa Inferred relationship Some
Carbidopa 12.5 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 2
Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa 25 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 1
Carbidopa 25 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 10 mg and levodopa 100 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 1
Carbidopa 10 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 25 mg and levodopa 100 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 2
Carbidopa 25 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 10 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 25 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 25 mg and levodopa 250 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 1
Carbidopa 25 mg and levodopa 250 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) True Carbidopa Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) False Carbidopa Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 2
Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Product containing carbidopa and levodopa in enteral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg prolonged-release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Some 3
Carbidopa 25 mg oral tablet Has precise active ingredient False Carbidopa Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Carbidopa Inferred relationship Some 2
Carbidopa 25 mg and levodopa 100 mg oral tablet Has precise active ingredient False Carbidopa Inferred relationship Some 1
Product containing carbidopa in oral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 1
Carbidopa 25 mg and levodopa 250 mg oral tablet Has precise active ingredient False Carbidopa Inferred relationship Some 1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) a pour principe actif (attribut) True Carbidopa Inferred relationship Some 3
Carbidopa 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient False Carbidopa Inferred relationship Some 1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start